Astec Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 74.82 | 91.57 | 120.30 |
| Operating Expense | 80.40 | 102.07 | 114 |
| Net Profit | -24.45 | -33.06 | -16.10 |
| Net Profit Margin | -32.68 | -36.10 | -13.38 |
| Earning Per Share | -11.39 | -16.86 | -8.21 |
| EBIDTA | -5.58 | -10.50 | 5.89 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 74.82 |
| Operating Expense | 80.40 |
| Net Profit | -24.45 |
| Net Profit Margin | -32.68 |
| Earning Per Share | -11.39 |
| EBIDTA | -5.58 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 381.30 | 458.18 | 628.17 |
| Operating Expenses Annual | 447.50 | 464.08 | 551.90 |
| Operating Profit Annual | -60.64 | -0.32 | 89.30 |
| Interest Annual | 36.71 | 25.24 | 20.74 |
| Depreciation | 43.37 | 35.84 | 32.47 |
| Net Profit Annual | -134.81 | -46.99 | 25.52 |
| Tax Annual | -6.31 | -14.89 | 9.33 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 381.30 |
| Operating Expenses Annual | 447.50 |
| Operating Profit Annual | -60.64 |
| Interest Annual | 36.71 |
| Depreciation | 43.37 |
| Net Profit Annual | -134.81 |
| Tax Annual | -6.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.46 | 0.46 | 0.54 |
| Cash Flow from Operations | -8.39 | 10.13 | 74.32 |
| Cash Flow from Investing | -15.13 | -134.98 | -112.07 |
| Cash Flow from Financing | 23.62 | 124.85 | 37.66 |
| Cash Flow at the End | 0.57 | 0.46 | 0.46 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.46 |
| Cash Flow from Operations | -8.39 |
| Cash Flow from Investing | -15.13 |
| Cash Flow from Financing | 23.62 |
| Cash Flow at the End | 0.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -15.90 | -0.07 | 14.22 |
| PBIT Margin (%) | -27.38 | -7.99 | 8.85 |
| PBT Margin (%) | -26.64 | -7.67 | 8.42 |
| Net PROFIT Margin (%) | -35.36 | -10.26 | 4.06 |
| Return On Networth / Equity (%) | -44.73 | -11.93 | 6.26 |
| Return On Networth /Employed (%) | -12.62 | -4.50 | 7.73 |
| Return On Assets (%) | -16.26 | -5.74 | 3.53 |
| Total Debt / Equity (X) | 1.74 | 1.06 | 0.76 |
| Asset Turnover Ratio (%) | 0.46 | 0.56 | 0.87 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -15.90 |
| PBIT Margin (%) | -27.38 |
| PBT Margin (%) | -26.64 |
| Net PROFIT Margin (%) | -35.36 |
| Return On Networth / Equity (%) | -44.73 |
| Return On Networth /Employed (%) | -12.62 |
| Return On Assets (%) | -16.26 |
| Total Debt / Equity (X) | 1.74 |
| Asset Turnover Ratio (%) | 0.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 519.78 | 402.35 | 332.57 |
| Total Current Assets Annual | 339.96 | 397.48 | 498.09 |
| Non Current Assets Annual | 540.46 | 576.67 | 480.75 |
| Total Shareholders Funds Annual | 234.07 | 368.68 | 418.79 |
| Total Assets Annual | 880.42 | 974.15 | 978.85 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 519.78 |
| Total Current Assets Annual | 339.96 |
| Non Current Assets Annual | 540.46 |
| Total Shareholders Funds Annual | 234.07 |
| Total Assets Annual | 880.42 |
EPS (INR)
Expected
-10.96
Reported
-11.35
Surprise
3.56%
Jun 2025
EPS beaten by 3.56%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.12%
